Small Cell Lung Cancer Limited Stage Clinical Trials

15 clinical trials for Small Cell Lung Cancer Limited Stage across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Durvalumab as Consolidation for Patients LS-SCLC — RECRUITING · PHASE2
• A Study of Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant Therapy and Biomarker Analysis in Limited-stage Small Cell Lung Cancer — RECRUITING · PHASE2
• Molecular Analysis and Treatment Options of SCLC — RECRUITING
• Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN) — ACTIVE_NOT_RECRUITING · PHASE2
• Study of Toripalimab for Limited-Stage Small Cell Lung Cancer Following Concurrent Chemoradiotherapy — TERMINATED · PHASE2
• Adebrelimab Maintenance Therapy After Concurrent Chemoradiotherapy with Hyperfractionated Radiotherapy in Limited-Stage Small Cell Lung Cancer — NOT_YET_RECRUITING · PHASE2
• A Clinical Study of TQB2450 Combined With Anlotinib in Limited-Stage Small Cell Lung Cancer Patients — NOT_YET_RECRUITING · PHASE3
• PCI and Brain MRI Follow-up vs Brain MRI Follow-up Alone in Limited-stage SCLC Patients — OTHER · NA
• Twice-daily SIB Radiotherapy Versus Standard Radiotherapy for Patients With SCLC — COMPLETED · NA
• Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung Cancer — COMPLETED · NA
• Concurrent Chemoradiotherapy Combination With Anlotinib for Limited-stage Small Cell Lung Cancer — OTHER · PHASE1
• Immunotherapy as Second-line in Patient With Small Cell Lung Cancer — COMPLETED · PHASE2
• A Prospective Study Comparing Two Radiotherapy Dose/Fraction and Omitting CTVs of the Primary Tumor in Limited SCLC — OTHER · PHASE2
• Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC — OTHER · PHASE2
• Image-Guided Functional Lung Avoidance Thoracic Radiotherapy for Lung Cancer: A Single-Blind Randomized Trial — OTHER · NA

Refine this search